In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss direct-to-consumer testing. Then, Dr. Pritt welcomes Matthew Binnicker, Ph.D., a microbiologist and virologist and chief scientific officer of Mayo Clinic Laboratories, for a conversation about accelerating innovation without compromising quality or safety. 

• Direct-to-consumer testing (00:38): Explore the rise of direct-to-consumer testing and the challenges that accompany it. 
• Evolving expectations for innovation (05:38): Understand why patient and clinician expectations are rising and how that is reshaping diagnostics.
• Safeguarding advances (07:23): Learn the foundational principles that protect quality and safety amid rapid innovation.
• Strategies for accelerating innovation (10:33): Discover practical ways to responsibly deliver novel solutions more quickly.

Note: Information in this post was accurate at the time of its posting.

Resources

• Five ways to move faster without compromising trust in diagnostics
• "Answers From the Lab” podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025
• 360Dx: 2025 highlights and takeaways for the clinical lab industry